One of the fun things about serving as your friendly neighborhood Stock Gumshoe is that boredom is never a challenge — each morning I get up and check the email box, and there’s invariably some bit of balderdash in there just waiting for a look-see. And today? No different, as you’ve no doubt surmised. Today […]
Articles
- Most Relevant
- Most Recent
“This safe growth stock should be a lock in your portfolio for the next 25 years. “You Must Invest Before April 1” That’s the headline that’s getting the attention of Gumshoe readers, as several folks have asked me today about the “Blue Chip Stocks of Tomorrow” pitch from Tony Daltorio. I’ve never looked at one […]
This was originally published as part of the Friday File on June 28, 2019. It has not been updated or revised (my position and disclosures remain the same). The ad under scrutiny today is for Jon Markman’s PowerElite service, which he says has a “retail price” of $228 but is “on sale” for $29/year at […]
This teaser starts, as so many of them do, by drawing a picture of the horrible future that a chosen stock can prevent … “On a hot summer day, just after the sun reaches its highest point, it begins… “Within minutes, cell phones go silent. Oil refineries shut down. Flights are grounded. Assembly lines grind […]
I’ve got a teaser pitch to solve for you, dear Irregulars — it’s from Roger Williams at Wall Street Daily, pitching his True Alpha letter by hinting at the stocks he thinks can double tomorrow in the “Penny Stock Index.” But first, a quick update on Criteo… A couple folks called yesterday’s (perhaps brief) crumpling […]
The variety of teaser ads which promise “free money” have been pretty popular over the years, and we’ve got a new one from Jason Williams that’s catching our readers’ attention… and is perhaps even more misleading than most… so let’s dig in. Williams’ ad starts like this: “Keep reading to discover how you can sign […]
This one comes from Steve Lord with Trend Investor, and he wants you to sign up to receive your “free” report: “The Age of Terror: How One Company Is Changing the Face of Homeland Defense.” The company he’s teasing about is a small cap homeland security play, though he spends most of his letter selling […]
follow up to 1.000 gainers where all 3 are under $10Defense Superstock #1: America’s Cyber Savior Defense Superstock #2: Unmanned Flight Defense Superstock #3: The Aircraft Experts
Does anyone know the name/Ticker symbol of this “supposed” small company that is “supposed to get (or has) a military contract for a hypersonic weapon to be supplied to all branches of the US military?
If you’re not an analyst or asset manager who specializes in the financial sector, and you don’t count on AIG, Lehman Brothers, or their many near competitors for a paycheck, right now might be a good time to take a step back, breathe a little, and thank whatever deity or lucky totem you might carry, […]
Pitched by Agora – Robert Burke and Louis Basenese – is this real or a stand up comedy routine. Smart Dust. An invisible network of data collection sensors …typically deployed in large swarms. They say CNN reports no one’s privacy will be secure anymore. A trillion of them by 2020. Smart Dust will transform our […]
I’m still able to generate some enthusiasm about specific stocks that I think are appealing enough to buy at these prices… but I find it very hard to be optimistic in a macro sense right now, it really feels to me as though the market is whistling past the graveyard and being far too sanguine […]
As I usually do in the weeks following the Value Investing Congress, I’m featuring a favorite idea from that Congress as our “Idea of the Month” this time around — and though it was hard to narrow down the list this year I decided to go with one of the smaller and more unusual ideas, […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He’s agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see his past articles and most recent comments here.] The death of Mr. Chiang, who was always kind, has never set well […]
What on earth is this about? In return for your subscription money a fellow who is disgruntled with Wall Street and the hedge fund world gives you nine magic digits and then the company involved has to pay you money. For what pray tell, Doc Gumshoe and the gang of gallant irregulars? By punching in […]
[Ed. Note: Here is the latest contribution from Dr. KSS, who writes for the Irregulars about medicine and biomedical stocks. As always, he has agreed to our trading restrictions and his words and thoughts are his own.] The Belle of the Everglades How To Profit From The Cure First of Two Parts Of the many […]
[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]
I follow SG by subscribing to the emailed comment notifications and use them to collect KSS’ comments for maintaining the Love KSS spreadsheet (more about that later, see the current KSS thread for its URL). I go to a thread online only (usually) when I need to clarify something about a KSS statement. Since […]
Options newsletter
Short-lived service that followed and recommended the investments owned by large money managers and well-respected investors (Warren Buffett, successful hedge fund managers, etc.) No longer publishing, Vardy left Eagle Financial for the Oxford Club in 2018.
I’ve got several teaser pitches percolating right now, but this one quickly rose to the top after a couple readers sent it to me this morning. Why? Not because I’m all that excited about the stock (it shouldn’t be a public company, frankly), but because the promises of absurd returns are so specific and over-the-top […]
Gold looks to be headed higher even with a strong dollar so what are the best ways to play the next bull run in gold? I know Travis has (SAND) in his portfolio but I’d like to know his thoughts as well as yours. Do long term call options make sense for more leverage? I’d […]
So what’s been happening since I last wrote to you, dear Irregulars? I’ve got a couple teaser picks to reveal for you in a moment, but first there are a few thoughts to get off the ol’ Gumshoe chest. We’ve seen a nice recovery from the healthcare REITs, which are still quite reasonably priced (DOC, […]
[ed. note: Michael Jorrin, who I like to call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes about non-financial health and medical issues for us a couple times a month — this time, he’s covering one of the many over-hyped health ads for “secret” supplements and treatments that we all see […]
Yesterday we dug into the teaser pitch for Blue Chip Gems that promised Bret Jensen’s “#1 Forever Stock for 2016,” and I told you I’d try to also name his other two picks… … so that’s today’s goal, identifying those other two members of Jensen’s “Top 3 Buy and Hold ‘Forever Stocks’” portfolio. We don’t […]
I didn’t do anything with my portfolio this week, and I don’t think we’ve had significant news that changes my opinion about any of the stocks I wrote about in our Annual Review about ten days ago, so today I’ll just dig into a teaser pitch for your Friday File edutainment. Here’s the intro to […]
As the stock market continues on its spiral downwards, drowning investors in the sea of despair forecast over the past year by Stansberry, Stockman and other pessimistic stock advisory writers, we constantly look for something to give credence to the old adage “when the going gets tough, the tough get going.” The problem is how? […]
Each year I go through all of the stocks that I either own personally or have brought to the attention of the Irregulars (there’s quite a bit of overlap on those lists), and I make sure to update my thoughts and opinion on that stock in an organized and, hopefully, disciplined way — that helps […]
“UCLA Researchers Stunned by Nobel Prize-Winning Cancer Breakthrough “One Little Shot to Kill Cancer Dead “Proven in clinical trials to eliminate lethal forms of cancer with a single dose “One small company owns the patent to this life-saving treatment “Its $5 shares are projected to surge 2,700% on an imminent FDA announcement” That intro comes […]
I hold back a few of my holdings from the stop-loss experiment I’ve been running over the past several months using Tradestops.com, including insurance-related names Berkshire Hathaway and Markel (both of which are in my top five individual equity holdings), but most of my positions are “exposed” to this experiment and are subject to be […]
We were talking about Warren Buffett just yesterday, and I also recently was looking into flights to go to the annual meeting in the Spring, so everyone’s favorite avuncular billionaire was on my mind this week… and it was almost like he was talking in my ear as I was plotting this “Idea of the […]
This ad for Sid Riggs’ Small-Cap Rocket Alert has been pitched a bunch of different ways — starting in August with the promise that they had some special way to get in early with a “royalty” on these “gold chips” that are being sent out (the new EMV chips in credit cards that are beginning […]
“This $2 American company is threatening a massive Wall Street shakeup handing you the opportunity for… 403% Gains In 3 Months“ Who can resist that pitch, right? The ad comes from Manny Backus for his Penny Stocks Guru service, which has been promoted in the past as a way to buy “safe penny stocks.” An […]
Today, as the Black Friday crowds have died down and we’ve all grown tired of watching people fight over “doorbuster” items in the “what has the world come to” video clips that are all-too-popular nowadays… we can talk about a different kind of ridiculous promotion. No, not towels for $1.60 or Xboxes for $99, but […]
This email pitch from Dr. Kent Moors for his Energy Advantage newsletter seems to have hit just about every inbox in North America. It has come in under a bunch of different subject lines, from “stunning breakthrough set to make OPEC obsolete” to “$5 stock make OPEC obsolete” to “Say ‘Goodbye’ to Your Electric Bill… […]
Nick Hodge’s ads from the Outsider Club open up with a promise that has been used to sell us all manner of stocks, from content delivery networks to faster WiFi technology to “Internet Royalties”: A faster internet. And who doesn’t want that, right? Most folks have decent access to broadband now, but we’re constantly reminded […]
I’ve never looked at a teaser pitch from Charles Payne before, but this one about a “buy and hold forever” stock caught my eye. Payne’s Smart Investing newsletter was started by Investorplace about six months ago as a way to capitalize, I expect, on his growing presence on Cable TV… you’ve probably seen him if […]
Generalist newsletter launched in Spring of 2015, recommending a variety of stocks, including blue chip-type ideas — marketing material says he sometimes “trades around” those positions and uses technical analysis to pick entry and exit points. Payne appears on Fox Business and also runs his own newsletter called Common Sense and a website called Wall […]
The “Internet of Things” is sure getting a lot of attention these days — most people throw around the forecasted numbers of $17-20 trillion as the market for this new technology, in which everything is interconnected and data is collected about you and your appliances and the roads you drive on and, well, everything. Even […]
Things are starting to heat up in earnings season, and the big takeaway for me so far, with Alphabet reporting yesterday, is more confirmation that mobile advertising is making some fortunes for shareholders — so today I’ll check in with Google/Alphabet, add some thoughts about Facebook and Twitter (which have yet to report), and update […]